Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

GRK2 in cardiovascular disease and its potential as a therapeutic target

Journal of Molecular and Cellular Cardiology(2022)10.1016/j.yjmcc.2022.07.008Source: DataRank Database

GRK2 in cardiovascular disease and its potential as a therapeutic target is a research paper published in Journal of Molecular and Cellular Cardiology (2022). On theSindex it has a DataRank of 0. It has been cited 29 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

29 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (10 grants)Impact (FWCI 1.95)OA: closedTopics (36)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (0/2)

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (2)

Walter J. Koch ORCID,Kimberly Ferrero ORCID

Live enrichment

PubMed:35878706 PMC:PMC12186197 OpenAlex:https://openalex.org/W4286636749

National Institutes of Health

Grant: P01 HL134608

National Institutes of Health

Grant: R01 HL061690

National Institutes of Health

Grant: R01 HL071818

National Institutes of Health

Grant: R01 HL157151

American Heart Association

Grant: 18MERIT33900036

NHLBI NIH HHS

Grant: P01 HL091799

NHLBI NIH HHS

Grant: T32 HL091804

NHLBI NIH HHS

Grant: F31 HL154567

NHLBI NIH HHS

Grant: P01 HL108806

NHLBI NIH HHS

Grant: P01 HL075443

FWCI

1.95

Citation Percentile

0.9%

Citation Trend

2023

2024

2025

2026

closedLicense: https://doi.org/10.15223/policy-004

publisherhttps://api.elsevier.com/content/article/PII:S0022282822001390?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0022282822001390?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.yjmcc.2022.07.008

repositoryhttps://pubmed.ncbi.nlm.nih.gov/35878706

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/12186197

Fields of Study

Receptor Mechanisms and SignalingProtein Kinase Regulation and GTPase SignalingNeuropeptides and Animal PhysiologyAnimalsHumansCardiovascular DiseasesG-Protein-Coupled Receptor Kinase 2Heart FailureMyocardiumReceptors, G-Protein-Coupled

MeSH Terms

AnimalsCardiovascular DiseasesHeart FailureHumansMyocardiumReceptors, G-Protein-CoupledG-Protein-Coupled Receptor Kinase 2

Keywords

Beta adrenergic receptor kinaseG protein-coupled receptor kinaseG protein-coupled receptorBioinformaticsMedicineDiseaseHeart failureNeuroscienceDrug discoveryBiologyComputational biologyPharmacologyReceptorPathologyInternal medicineCardiovascular diseaseParoxetineGrk2Gpcr

Sustainable Development Goals

SDG 0: Good health and well-being

GRK2 in cardiovascular disease and its potential as a therapeutic target

FAIR Checklist

Authors (2)

Funding (10 grants)

Impact

Open Access

Topics